REAL-WORLD EFFECTIVENESS OF BIOLOGIC THERAPIES IN SEVERE ASTHMA: A REAL-WORLD MONOCENTRIC RETROSPECTIVE STUDY ASSESSING CLINICAL REMISSION AND DISEASE CONTROL IN T2 PHENOTYPE PATIENTS AFTER 12 AND 18 MONTHS OF TREATMENT